How Customers Are Advancing Clinical Trials with Medidata

More than 2,200 life sciences organizations use Medidata to run faster, smarter, and more connected trials. See how customers are improving clinical operations, strengthening data quality, engaging patients, and applying AI across the clinical lifecycle.

Video transcript: We value having a unified platform utilizing metadata's multiple systems, not only EDC but the RTSM, the IRT, the adjudication piece. What that is doing for our sites is it gives them a very similar platform. They're able to go in, they see the same areas, they feel very comfortable, and that's a really low burden for the site so they're able to go in and utilize multiple components, but it's all in one unified. And then from a worldwide perspective, all the data is in one central location. So it's unifying the data, it's giving us faster access to the data, the data is there, limited mapping so all the data flows in very seamlessly and that refresh to receive that data is pretty instantaneously that we're seeing.

The Power of a Unified Platform

Success Stories

Video transcript: At Corecept, we are using Clinical Data Studio. We're using RTSM. We're using TSTV. We're using RAVE. And we are getting ready to embark on RBQM as well. We use a suite of products in RAVE from Medidata, and I think for us it's such a valuable experience. It's giving us such a depth and breadth, and changing our whole spectrum in how we approach our data and how we integrate our data will continue to grow. It's an extremely valuable experience for my data management team, for myself, and my relationship with Medidata has absolutely changed. The word transformative keeps coming up, but it truly is for us. It's become a transformative journey for us.

Pivotal Shift to Integrated Data Management

"We use a suite of products from Medidata and for us it’s such a valuable experience, changing how we approach our data and how we integrate our data. The word transformative keeps coming up but it truly is for us."

Video transcript: Well, we're spending time with Medidata right now doing work around a clinical data studio, which I think is a fantastic evolution of that. It's starting to bring a lot of the capabilities together. Medidata is, I think, running in the in the absolute right direction to look at clinical data as one big conglomeration of data, safety, efficacy, regardless of the underlying systems. So moving in that direction, I think, is, is very positive for us. It allows us to, I think, get a better view, present the data to the sponsors more rapidly with better quality, and answer the questions that a lot of sponsors have around, you know, where is my study? Where is my data? How are things really performing? That holistic view of clinical data is, I think, probably one of the great differentiators that Medidata is bringing in. Looking at Clinical Data Studio, the primary value that, that I've communicated is clean data faster. Very, very simple, very, very straightforward, very, very powerful. Having that context, all of the clinical data, all of the endpoint data in one place regardless of underlying system, it moves the needle. It eases the, the data cleansing, process, makes things easier for data management, and presents, I I I think, the unified view of the study in a very, very clean and efficient manner for medical. The ability to get uplift on medical, to turn medical reviews around more quickly to give them that holistic view, is is really, really critical. And, of course, tying in risk based monitoring. One of the big challenges with a with with an atomized eClinical architecture is you have a number of different vendors who have slightly different takes on the same data. We're all looking at the same clinical data. If your RBM system has a slightly different view of what the data definitions may be, then your medical visualization or your data management team, the opportunity for drift or confusion in the data, it's magnified. And that's very, very critical to to the success of the trial, obviously. So having a single context that teams can work in, a single set of information, a single set of reports that people can utilize for their own particular goals, their own within the roles is, I think, very, very powerful and gets us out of, again, that stove piping by technology. You know, is it ECOA? Is it EDC? Is it labs? It doesn't matter. It's endpoint data, and we wanna deal with it as endpoint data.

Enabling a Holistic View of Clinical Data

"Looking at Clinical Data Studio, the primary value is clean … data… faster. It’s very simple, very straightforward, and very powerful. Having that context, of all the clinical data, all of the endpoint data, in one place regardless of underlying system, it moves the needle."

Video transcript: The adoption of the Medidata Designer was absolutely fundamental for us because we have all the development phases of the new CRF in house. With the designer, we had the occasion to accelerate in terms of timelines and also to make more efficient the processes of the new development of the CRF. The most important element from our perspective, huge potentiality that we have in this tool with the AI integration. It's clear that with the designer you can have an immediate help during the configuration phases, But moreover, what is absolutely important for us in terms of development phases, of course, is the time reduction in the test phases. And we know, we are absolutely sure that with the AI, we can simulate a test phase potentially with one second, with one click.

Accelerating Development Timelines and Boosting Efficiency with AI Integration.

"The adoption of Medidata Designer was absolutely fundamental for us because we develop all our CRFs in-house. With Designer, we could accelerate timelines and make our process more efficient."

Video transcript: I'm in charge of ClinOps, so we use the CTMS reports, we use the dashboards that are within the CTMS and those are super easy to manipulate to whatever data you want. You can pull things in from certain listings, you can pull certain data points in, you can do ranges, you can do patients, you can drill down to the site level, you can drill up, you can go down. It makes it really easy to move around depending on what you need to look at. We have a range of people within the clinical team that some people are super technical and some people are not as technical, but metadata's tools make it pretty easy to adapt to whatever the end user's capabilities are. The tools and the app that's available for patients, it's very simple. We also use patient payments, so if you're using ePro and patient payments, makes it even easier because everything's right there for the patients to do all in one fell swoop. We absolutely loved that Metadata's platform gives us flexibility in the way to deliver patients the funds, the reimbursements, stipends, whatever it might be for the study, and it meets them where they're at because some patients want a card, some patients don't. Some people like Venmo, some people like PayPal. It depends on whatever the patient's needs are. You're doing travel concierge now, which is great. That means I have one less vendor that I need to contract with and one less communication channel that I need to worry about and it again seamlessly works into patient payments. So I'm really excited about that change. I think it's a natural progression of patient payments and it will make it easier for the patients to not have a separate contact they need to reach out to to travel and arrange their travel arrangement. Metadata is known, constantly looking for how it can do the next thing better than everyone else, and by being partners with Metadata, it gives us that ability too. Hi.

Adaptable Tools to Meet End User Capabilities

"Medidata is known for constantly looking for how it can do the next thing better than everyone else. And by being partners with Medidata, it gives us that ability too."

Video transcript: So I'm the associate director of site payments. It's just me and a contractor that manage all of site payments. My first time working with Medidata was actually my first time working in clinical site payments. It was not necessarily an ideal scenario because we had an urgent need that needed to be rectified as quickly as possible. It was a quick transition, but the partnership with our team at Medidata has been invaluable. They were able to customize the way that we did the implementation to kind of meet our needs and let us kind of dictate certain ways that we wanted to transition. Invoices are getting paid timely. Payments are being received by sites. That's when we hear from investigators the most, is when there are problems, when they feel like they're not getting paid. I can say that since starting the managed services process and kind of getting everybody on board, overall we're hearing from sites less because the system is working. Having worked with multiple payment vendors, my favorite things about Medidata is the wonderful balance of ownership with expertise that we know that we can really rely on. But I also know that I have access to information, answers, you know, at my own fingertips, as well as relying on my team. And again, I'll say the people are like the icing on the cake.

Ensuring Timely Management of Site Payments

"The people at Medidata’s Site Payments Managed Services team were the icing on the cake and have been instrumental to our site payments success."

Spotlight Stories

From Days to Hours: See how Veramed and Medidata Accelerated Biometric Workflows

Read Veramed Case Study

Discover how GCAR uses Health Record Connect (HRC) to drive site success through simplified data capture, faster rollouts, and minimal integration effort.

Watch GCAR Video

Discover how Cerevance transformed its clinical trial operations by replacing delayed, inaccurate site payments with Medidata Site Payments Managed Services.

Read Cerevance Case Study

See how Aperio uses the Medidata platform to make complex oncology trials more efficient and streamlined

Watch Aperio Video

Here’s how ONCONOVA uses Rave to improve patient screening

Read Onconova Case Study

Here’s how MEDICENNA kept a potentially life-saving treatment in the game

Read Medicenna Case Study

Here’s how next generation data management helped REZOLUTE accelerate completion of a complex trial

Read Rezolute Case Study

What Our Customers Are Saying

"The one thing that I find the most valuable with the relationship with Medidata is it's a very direct and transparent conversation. It is a give and take... it's a constant open dialogue and it's collaborative in nature."

Amy Plodek, BS, MHA

Senior Director, Clinical Data Management

"We use trusted partners like Medidata for tool sets to drive the AI narrative. With the way the market is going, it is too risky not to partner with Medidata on the full clinical platform."

Carmen Stiles

SVP, Global Analytics

“Having a unified platform really cuts down on the number of workflows that you normally would have to have when you're using multiple vendors. Data is flowing through the one system. You have the traceability at your hand. You're removing two or three steps. All that documentation flows - removing the redundancy from multiple systems. It allows us to be efficient, keep costs down for us and our clients.”

Mike Mendoza

VP, Biometrics and Data Science

“Medidata is a global brand that everyone knows, and everyone is happy to use… The seamless experience … creates a much easier experience for us. Sites are entering data very quickly. They know the system and they know these modules back and forth. They don’t have a lot of questions. And there’s a lot of confidence in that.”

Karis Oasan

A. Director Clinical Affairs

Heidi Varghese

Director of Finance

“… Our partnership with Medidata has been very collaborative from a data management perspective in rolling out all the new applications and tools and integrating them with EDC. It’s made data management easier for reviewing the data, drawing out metrics, and building the forms. It’s an easier platform to design and then work with integrating new tools like RTSM or eCOA/ePRO.”

Cathy Hult

Director of Data Management

“The effect that we have seen is the achievement of end of study and ‘on to market’ times reducing rapidly from ten years to an average of six years; shrinking end-of-study times by four years translates to faster delivery of new treatments to patients in need.”

Dilshat Djumanov

Director of Data Science

In the News

Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Lifecycle, Bolstering Study Execution and Delivery Excellence

Platform

Resources

Let's Talk